Lasa Supergenerics Reports Mixed Financial Results Amid Declining Sales and Profitability Challenges in August 2025

Aug 14 2025 01:56 PM IST
share
Share Via
Lasa Supergenerics has reported its financial results for the quarter ending June 2025, revealing a significant year-on-year increase in Profit After Tax to Rs 9.07 crore. However, the company faced challenges with a 35.12% decline in net sales and a negative operating profit, indicating operational difficulties.
Lasa Supergenerics, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 13, 2025, indicate a notable adjustment in evaluation, with the stock's score reflecting a significant decline over the past three months.

The financial data reveals a positive trend in Profit After Tax (PAT), which stands at Rs 9.07 crore, showcasing a substantial year-on-year growth of 197.95%. This figure surpasses the PAT from the preceding twelve-month period, indicating a turnaround in profitability for the company.

Conversely, the results also highlight challenges faced by Lasa Supergenerics. Net sales for the quarter have reached Rs 20.01 crore, marking a year-on-year decline of 35.12% and representing the lowest sales figure in the last five quarters. Additionally, the operating profit has dipped to Rs -0.50 crore, and the operating profit margin has fallen to -2.50%, reflecting a decrease in operational efficiency. Earnings per share have also reached a low of Rs -4.22, indicating a decline in profitability for shareholders.

Overall, Lasa Supergenerics' latest financial results present a mixed picture, with significant evaluation changes noted in its performance metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News